An update on Brexit and IP rights for pharmaceutical companies

Charlotte Tillett and Kate Maguire with S&B provide an update on where we are with Brexit and IP rights in the pharmaceutical sector.

Please see their recent article in Pharmaceutical Market Europe (PME).